Veradigm EBITDA 2012-2022 | MDRX
Veradigm ebitda from 2012 to 2022. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
|
Veradigm Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $-141 |
| 2023 | $83 |
| 2022 | $89 |
| 2021 | $150 |
| 2020 | $95 |
| 2019 | $99 |
| 2018 | $29 |
| 2017 | $170 |
| 2016 | $204 |
| 2015 | $193 |
| 2014 | $135 |
| 2013 | $51 |
| 2012 | $164 |
| 2011 | $269 |
|
Veradigm Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2022-12-31 | $20 |
| 2022-09-30 | $39 |
| 2022-06-30 | $9 |
| 2022-03-31 | $21 |
| 2021-12-31 | $57 |
| 2021-09-30 | $35 |
| 2021-06-30 | $34 |
| 2021-03-31 | $24 |
| 2020-12-31 | $12 |
| 2020-09-30 | $36 |
| 2020-06-30 | $20 |
| 2020-03-31 | $28 |
| 2019-12-31 | $-81 |
| 2019-09-30 | $61 |
| 2019-06-30 | $61 |
| 2019-03-31 | $58 |
| 2018-12-31 | $-47 |
| 2018-09-30 | $48 |
| 2018-06-30 | $-13 |
| 2018-03-31 | $41 |
| 2017-12-31 | $-43 |
| 2017-09-30 | $79 |
| 2017-06-30 | $73 |
| 2017-03-31 | $61 |
| 2016-12-31 | $36 |
| 2016-09-30 | $61 |
| 2016-06-30 | $61 |
| 2016-03-31 | $46 |
| 2015-12-31 | $60 |
| 2015-09-30 | $50 |
| 2015-06-30 | $47 |
| 2015-03-31 | $36 |
| 2014-12-31 | $43 |
| 2014-09-30 | $24 |
| 2014-06-30 | $35 |
| 2014-03-31 | $33 |
| 2013-12-31 | $19 |
| 2013-09-30 | $3 |
| 2013-06-30 | $15 |
| 2013-03-31 | $14 |
| 2012-12-31 | $13 |
| 2012-09-30 | $47 |
| 2012-06-30 | $55 |
| 2012-03-31 | $48 |
| 2011-12-31 | $81 |
| 2011-09-30 | $68 |
| 2011-06-30 | $65 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.490B | $0.000B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Enovis (ENOV) | United States | $1.405B | 7.40 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Phreesia (PHR) | United States | $0.490B | 50.38 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |